Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Revenue: 2020-2025

Historic Revenue for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $159,000.

  • Silence Therapeutics' Revenue fell 89.39% to $159,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 25.38%. This contributed to the annual value of $43.3 million for FY2024, which is 36.71% up from last year.
  • Per Silence Therapeutics' latest filing, its Revenue stood at $159,000 for Q3 2025, which was down 29.02% from $224,000 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Revenue ranged from a high of $4.3 billion in Q1 2021 and a low of $142,000 during Q1 2025.
  • For the 3-year period, Silence Therapeutics' Revenue averaged around $6.5 million, with its median value being $2.6 million (2023).
  • Per our database at Business Quant, Silence Therapeutics' Revenue tumbled by 99.83% in 2021 and then soared by 871.33% in 2024.
  • Over the past 5 years, Silence Therapeutics' Revenue (Quarterly) stood at $4.6 million in 2021, then climbed by 21.44% to $5.6 million in 2022, then plummeted by 53.39% to $2.6 million in 2023, then skyrocketed by 871.33% to $25.3 million in 2024, then tumbled by 89.39% to $159,000 in 2025.
  • Its Revenue stands at $159,000 for Q3 2025, versus $224,000 for Q2 2025 and $142,000 for Q1 2025.